Interest in genomic SNP testing for prostate cancer risk: a pilot survey

BACKGROUND: Advancements in genomic testing have led to the identification of single nucleotide polymorphisms (SNPs) associated with prostate cancer. The clinical utility of SNP tests to evaluate prostate cancer risk is unclear. Studies have not examined predictors of interest in novel genomic SNP t...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Michael J, Ruth, Karen J, Chen, David YT, Gross, Laura M, Giri, Veda N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396119/
https://www.ncbi.nlm.nih.gov/pubmed/25874018
http://dx.doi.org/10.1186/s13053-015-0032-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396119/
https://www.ncbi.nlm.nih.gov/pubmed/25874018
http://dx.doi.org/10.1186/s13053-015-0032-3

Ejemplares similares